ENLIVEX THERAPEUTICS LTD's ticker is and the CUSIP is M4130Y956. A total of 2 filers reported holding ENLIVEX THERAPEUTICS LTD in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $0 | -100.0% | 100 | -66.7% | 0.00% | – |
| Q3 2022 | $1,000 | – | 300 | +200.0% | 0.00% | – |
| Q4 2021 | $0 | -100.0% | 100 | -99.3% | 0.00% | – |
| Q3 2021 | $128,000 | 0.0% | 14,400 | 0.0% | 0.00% | – |
| Q2 2021 | $128,000 | -49.4% | 14,400 | +6188.2% | 0.00% | – |
| Q1 2021 | $253,000 | +416.3% | 229 | +288.1% | 0.00% | – |
| Q4 2020 | $49,000 | – | 59 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 2,100 | $21,000 | 0.00% |
| SIMPLEX TRADING, LLC | 14,400 | $128,000 | 0.00% |